drug approval expansion – Patient Worthy

source: pixabay.com

LIVMARLI Now Approved for Children with Alagille Syndrome as Young as 3 Months Old

Post author:Jessica Lynn
Post published:March 29, 2023
Post category:Alagille Syndrome

In many rare conditions, early diagnosis and treatment typically correspond with better outcomes. Prior to March 2023, LIVMARLI (maralixibat) was approved for the treatment of cholestatic pruritus related to Alagille…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More